Cervical Intraepithelial Neoplasia
146
13
19
82
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Published Results
21 trials with published results (14%)
Research Maturity
82 completed trials (56% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
4.8%
7 terminated out of 146 trials
92.1%
+5.6% vs benchmark
17%
25 trials in Phase 3/4
26%
21 of 82 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 82 completed trials
Clinical Trials (146)
Gene Therapy Follow up Protocol for Subjects Previously Enrolled in NCI Center for Immuno-Oncology Studies
Compass - Randomised Controlled Trial of Primary HPV Testing for Cervical Screening in Australia
A Novel, Low-Cost, Handheld 3D Imaging System for Improved Screening for Cervical Neoplasia in Resource-Limited Settings
Point of Care - Triage and Treatment for Cervical Pre-cancer
Pembrolizumab for the Treatment of Cervical Intraepithelial Neoplasia
E7 TCR T Cells for Human Papillomavirus-Associated Cancers
A Study of ABI-2280 Vaginal Insert (Previously Referred to as ABI-2280 Vaginal Tablet) in Participants With Cervical Intraepithelial Neoplasia
Participation in Screening for Cervical Cancer: Interest of a Self-sampling Device Provided by the General Practitioner
Effect of Curcumin in Treatment of Squamous Cervical Intraepithelial Neoplasias (CINs)
Validation of a Lab-free Low-cost Screening Test for Prevention of Cervical Cancer
Cervical Cancer Screening of Postmenopausal Women in Low- and Middle-income Countries Using HPV Self-sampling and Triage by Genotyping and Cytology
Human Papillomavirus Self-sampling for Enhancing Cervical Screening During the War in Ukraine
Incidence of Cervical Cancer in HPV-positive Women With Low-grade Cytological Abnormalities
Cervical Intraepithelial Neoplasia Screening Using Liquid-Based Pap Smear Among Egyptian Women
Efficacy, Immunogenicity and Safety Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli)
Comparisons of the Effects and Clinical Outcomes of CH2 Vaginal Gel Versus Placebo on CIN1
Fenofibrate in Patients With Cervical Intraepithelial Neoplasia and Invasive Cervical Carcinoma
Long-term Effectiveness and Immuno-persistence Study of a Recombinant HPV 16/18 Bivalent Vaccine in Preadolescent Girls
Comparison of Cervical CIN II/III Treatment Outcomes With Thermal Ablation Device
Biospecimen Collection and Testing for the Prevalence of Anal Dysplasia and Anal Cancer in Patients With Cervical, Vaginal and Vulvar Dysplasia and Cancer